You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Association between the five biomarkers and the stage of fibrosis (METAVIR F score) and between the biomarkers and the presence of steatosis

From: Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C

Marker METAVIR F Steatosis
APRI 0.34 (−0.03–0.63), p = 0.06 0.42 (0.08–0.68), p = 0.02
M-APRI 0.44 (0.08–0.69), p = 0.01 0.40 (0.05–0.67), p = 0.02
FIB-4 0.18 (−0.20–0.51), p = 0.35 0.09 (−0.27–0.44), p = 0.61
M-FIB-4 0.36 (−0.01–0.64), p = 0.05 0.40 (0.04–0.66), p = 0.02
B-AST 0.56 (0.24–0.77), p = 0.001 0.32 (−0.05–0.61), p = 0.08
  1. Data are presented as correlation coefficients (95% confidence intervals) and p-values